Precision medicine startup launches with Eli Lilly deal and $20M in VC funds

A new precision medicine startup has emerged from stealth with a drug licensed from Eli Lilly& Co. and around $20 million in venture capital.

Source: bizjournals.com Health Care:Biotechnology headlines - June 29, 2021 Category: Biotechnology Authors: Rowan Walrath Source Type: news